Carregant...
Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy
PURPOSE: To compare the outcomes of treatment with intravitreal bevacizumab (IVB) versus observation in central serous chorioretinopathy (CSCR). METHODS: In a retrospective comparative study, records of 45 patients with CSCR were reviewed. Twenty-two patients received IVB (1.25 mg/0.05 ml) while 23...
Guardat en:
| Publicat a: | J Ophthalmic Vis Res |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Medknow Publications & Media Pvt Ltd
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4860989/ https://ncbi.nlm.nih.gov/pubmed/27195087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2008-322X.180700 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|